There are several GLP-1 inhibitors on the market, including Ozempic (semaglutide), Wegovy (semaglutide), and Monjourno (tirzepatide), that are approved for the management of type 2 diabetes
Injections typically deliver a higher dose of the medication compared to oral forms, resulting in more significant weight loss in clinical studies
117(4): 726-727 L-Carnitine Supplementation in the Diabetic Heart This Short Editorial is referred by the Research article "Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
If weight is morally neutral, as I believed, Id done nothing wrong by losing it, but in truth the body is contested ground
& Yavin, E